unknown
Stage
About
HarborSite develops a programmable site-specific recombinase platform for precise and efficient therapeutic gene insertion into safe genomic locations, enabling potential one-time treatments for genetic and age-related diseases.
Explore HarborSite's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.